{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:38:41Z","timestamp":1760315921847,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81302749"],"award-info":[{"award-number":["81302749"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Program of Zhejiang Chinese Medical University","award":["711200E008","2014ZR05"],"award-info":[{"award-number":["711200E008","2014ZR05"]}]},{"name":"Program for Zhejiang Leading Team of S&T Innovation","award":["2011R50014"],"award-info":[{"award-number":["2011R50014"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.eplepsyres.2016.01.001","type":"journal-article","created":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T13:15:19Z","timestamp":1452172519000},"page":"104-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["The efficacy and safety of rufinamide in drug-resistant epilepsy: A meta-analysis of double-blind, randomized, placebo controlled trials"],"prefix":"10.1016","volume":"120","author":[{"given":"Zhenghao","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huawei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2016.01.001_bib0005","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/bcp.12479","article-title":"Exposure to rufinamide and risks of CNS adverse events in drug-resistant epilepsy: a meta-analysis of randomized, placebo-controlled trials","volume":"78","author":"Alsaad","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2016.01.001_bib0010","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrneurol.2011.73","article-title":"Epilepsy: efficacy of epilepsy surgery: what are the questions today?","volume":"7","author":"Berg","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.eplepsyres.2016.01.001_bib0015","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrd2997","article-title":"Key factors in the discovery and development of new antiepileptic drugs","volume":"9","author":"Bialer","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.eplepsyres.2016.01.001_bib0020","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1528-1167.2010.02729.x","article-title":"A randomized, double-blind, placebo-controlled, parallel-group study of rufinamide as adjunctive therapy for refractory partial-onset seizures","volume":"52","author":"Biton","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2016.01.001_bib0025","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/j.1528-1167.2009.02160.x","article-title":"Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: a randomized placebo-controlled trial","volume":"50","author":"Brodie","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2016.01.001_bib0030","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.eplepsyres.2009.12.003","article-title":"A 24-week multicenter, randomized, double-blind, parallel-group, dose-ranging study of rufinamide in adults and adolescents with inadequately controlled partial seizures","volume":"88","author":"Elger","year":"2010","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2016.01.001_bib0035","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1212\/WNL.0b013e3181a55f90","article-title":"Sudden unexpected near death in epilepsy: malignant arrhythmia from a partial seizure","volume":"72","author":"Espinosa","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2016.01.001_bib0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2288-7-5","article-title":"Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data","volume":"7","author":"Friedrich","year":"2007","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.eplepsyres.2016.01.001_bib0045","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1212\/01.wnl.0000303813.95800.0d","article-title":"Rufinamide for generalized seizures associated with Lennox\u2013Gastaut syndrome","volume":"70","author":"Glauser","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2016.01.001_bib0050","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.seizure.2012.02.006","article-title":"Rufinamide as an adjuvant treatment in children with Lennox\u2013Gastaut syndrome","volume":"21","author":"Kim","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2016.01.001_bib0055","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1684\/epd.2013.0557","article-title":"Short-term efficacy and tolerability of rufinamide adjunctive therapy in children with refractory generalised epilepsy","volume":"15","author":"Kim","year":"2013","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.eplepsyres.2016.01.001_bib0060","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.clineuro.2012.09.021","article-title":"Effectiveness and tolerability of rufinamide in children and young adults with Lennox\u2013Gastaut syndrome: a single center study in Korea","volume":"115","author":"Lee","year":"2013","journal-title":"Clin. Neurol. Neurosurg."},{"year":"2015","series-title":"Pharmacokinetics and Tolerability of Rufinamide in Healthy Chinese Subjects","author":"Li","key":"10.1016\/j.eplepsyres.2016.01.001_bib0065"},{"key":"10.1016\/j.eplepsyres.2016.01.001_bib0070","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0140-6736(12)61455-X","article-title":"Uncovering the neurobehavioural comorbidities of epilepsy over the lifespan","volume":"380","author":"Lin","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2016.01.001_bib0075","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.eplepsyres.2016.01.001_bib0080","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.eplepsyres.2014.08.019","article-title":"Rufinamide as an adjunctive therapy for Lennox\u2013Gastaut syndrome: a randomized double-blind placebo-controlled trial in Japan","volume":"108","author":"Ohtsuka","year":"2014","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2016.01.001_bib0085","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000051263","article-title":"Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials","volume":"12","author":"Oremus","year":"2001","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.eplepsyres.2016.01.001_bib0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0920-1211(00)00185-6","article-title":"Rufinamide: a double-blind, placebo-controlled proof of principle trial in patients with epilepsy","volume":"43","author":"Palhagen","year":"2001","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2016.01.001_bib0095","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1046\/j.1528-1157.2002.33800.x","article-title":"Temporal lobe epilepsy surgery: outcome, complications, and late mortality rate in 215 patients","volume":"43","author":"Salanova","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2016.01.001_bib0100","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5070\/D37DN5M9VT","article-title":"A case of Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) related to rufinamide","volume":"19","author":"Shahbaz","year":"2013","journal-title":"Dermatol. Online J."},{"key":"10.1016\/j.eplepsyres.2016.01.001_bib0105","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11940-010-0079-4","article-title":"New antiepileptic drugs: lacosamide, rufinamide, and vigabatrin","volume":"12","author":"Strom","year":"2010","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.eplepsyres.2016.01.001_bib0110","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/brain\/awh449","article-title":"Long-term seizure outcomes following epilepsy surgery: a systematic review and meta-analysis","volume":"128","author":"Tellez-Zenteno","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.eplepsyres.2016.01.001_bib0115","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.22142","article-title":"Mesial temporal lobe epilepsy: how do we improve surgical outcome?","volume":"68","author":"Thom","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.eplepsyres.2016.01.001_bib0120","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.pediatrneurol.2010.12.005","article-title":"Efficacy of rufinamide in drug-resistant epilepsy: a meta-analysis","volume":"44","author":"Verrotti","year":"2011","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2016.01.001_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1535-7511.2009.01336.x","article-title":"Rufinamide: a novel broad-spectrum antiepileptic drug","volume":"10","author":"Wheless","year":"2010","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.eplepsyres.2016.01.001_bib0130","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1038\/511S7a","article-title":"Perspective: the surgical solution","volume":"511","author":"Wiebe","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.eplepsyres.2016.01.001_bib0135","doi-asserted-by":"crossref","first-page":"e0120884","DOI":"10.1371\/journal.pone.0120884","article-title":"The effectiveness of the problem-based learning teaching model for use in introductory Chinese undergraduate medical courses: a systematic review and meta-analysis","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS ONE"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121116300018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121116300018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:35:14Z","timestamp":1760276114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121116300018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":27,"alternative-id":["S0920121116300018"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2016.01.001","relation":{},"ISSN":["0920-1211"],"issn-type":[{"type":"print","value":"0920-1211"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy and safety of rufinamide in drug-resistant epilepsy: A meta-analysis of double-blind, randomized, placebo controlled trials","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2016.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}